Presentation
Value
Biomedical Applications with Metallic Nanoparticles
Mission R&D in nanomedicine and bionanotechnology. To carry out new therapies based on the use of nanotechnology Manufacturing of developed products
Conjugated Nanoparticle development
Proof of Concept
Application Manufacturing
Platform Technology: Conjugation
Molecule
Protein Nano-Carrier
Peptide
DNA RNA
Cosmetic Applications Novel nanomaterials for a new generation of active ingredients delivery systems
Mission: Introduce Gold Carriers into the Cosmetics Industry
1
Gold Carriers for Peptides topical delivery Manufacturing
2
Golden Hyaluronan (Gold Carriers + Hyaluronic Acid) Validation
3
Gold Carriers conjugated to active ingredients Development
Golden Hyaluronan
Improvement : • Skin Penetration • Stability by increasing HA Cross-linking
Medical Applications EDS AuroMag
Business Pipeline. Nanomedicine
Cobalt
AuroMag
Gold
+
Co@Au
Pipeline Business Strategy
Platform Tech
DISCOVERY
Conjugate Design
Partnering
QUALITY
Active Substance
NON-CLINICAL
Financing Endor
Finance
Long term
Long term
Medium term Venture Cap
Short term
Customers Diagnostics
Pharma
Pharma
Cosmetics Processes
R&D Cosm
R&D medicine
R&D Pharma
Learning Team
Facilities
Team
Facilities
Financing Endor
Self - Financing
Venture Capital
• Different Time To Market products
• Long term objectives
• Different business models
• One business models
• R&D segmentation
• Focused R&D
• Revenues
Starting Endor
IP: Competitive position into market • Protected • Tested • Flexible and versatile: technology platform for innovation
Thank you‌